Volume 22 (2023)
Volume 21 (2022)
Volume 20 (2021)
Volume 19 (2020)
Volume 18 (2019)
Volume 17 (2018)
Volume 16 (2017)
Volume 15 (2016)
Volume 14 (2015)
Volume 13 (2014)
Volume 12 (2013)
Volume 11 (2012)
Volume 10 (2011)
The association of serum carnitine levels with severity of fatigue in patients with multiple sclerosis: A pilot study

Mohammad Hossein Harirchian; Siavash Babaie; Nika Keshtkaran; Sama Bitarafan

Volume 22, Issue 1 , January 2023, , Pages 30-34

  Background: Fatigue is a common complaint of patients with multiple sclerosis (MS), adversely affecting their quality of life. There is a lot of evidence showing that carnitine deficiency is linked to fatigue development and severity in some conditions. This study aimed to evaluate the association between ...  Read More

Diet and disease-related outcomes in multiple sclerosis: A systematic review of clinical trials

Mohammad Hossein Harirchian; Elmira Karimi; Sama Bitarafan

Volume 21, Issue 1 , January 2022, , Pages 52-63


  Background: A growing number of clinical trials have investigated the role of diet in multiple sclerosis (MS) patients. We systematically reviewed the literature for clinical trials to assess the impact of different kinds of diets on MS-related outcomes.Methods: We searched MEDLINE, EMBASE, and Web of ...  Read More

Prevalence of depression among Iranian patients with myasthenia gravis during 2017-2018

Kiana Amani; Payam Sarraf; Alireza Abkhoo; Abbas Tafakhori; Farzad Fatehi; Sama Bitarafan; Elmira Agah; Mamak Shariat

Volume 19, Issue 4 , October 2020, , Pages 162-166


  Background: Myasthenia gravis (MG) is a chronic neuromuscular disease, which physically and mentally affects the patient’s life, with depression being one of the most important psychological complications in these patients. This study aims to investigate the prevalence of depression and its associated ...  Read More

Impact of supplementation with "multivitamin-mineral" specially formulated to improve fatigue and inflammatory state in patients with multiple sclerosis: A triple-blind, randomized, placebo-controlled trial

Sama Bitarafan; Elmira Karimi; Abdorreza Naser Moghadasi; Razieh Sadat Kazemi-Mozdabadi; Zinat Mohammadpour; Mohammad Ali Sahraian

Volume 19, Issue 4 , October 2020, , Pages 180-189


  Background: Multiple sclerosis (MS) is an inflammatory disease of the central nervous system (CNS) with the most common complaint of fatigue. A high number of patients with MS are interested in taking dietary supplements as a complementary therapy. We propose a specially formulated supplement for patients ...  Read More

The trend of incidence and burden of neurological disease in Iran between 1990 and 2017: Based on global burden of disease estimations

Hedayat Abbastabar; Sama Bitarafan; Mohammad Hossein Harirchian

Volume 18, Issue 3 , August 2019, , Pages 134-142

  Neurological disease contributes significantly to morbidity and mortality in different ages and geographic areas around the world. The purpose of the current study was to investigate the incidence and disability-adjusted life years (DALYs) trend of neurological disease in Iran during 27 years ago. We ...  Read More

Molecular mechanisms of omega-3 fatty acids in the migraine headache

Neda Soveyd; Mina Abdolahi; Sama Bitarafan; Abbas Tafakhori; Payam Sarraf; Mansoureh Togha; Ali Asghar Okhovat; Mahsa Hatami; Mohsen Sedighiyan; Mahmoud Djalali; Niyaz Mohammadzadeh-Honarvar

Volume 16, Issue 4 , October 2017, , Pages 210-217

  Migraine is a common chronic inflammatory neurological disease with the progressive and episodic course. Much evidence have shown a role of inflammation in the pathogenesis of migraine. Omega-3 fatty acids are an important components of cell membranes phospholipids. The intake of these fatty acids is ...  Read More

The comparison of anti-seizure and tocolytic effects of phenytoin and magnesium sulphate in the treatment of eclampsia and preeclampsia: A randomised clinical trial

Maryam Khooshideh; Majid Ghaffarpour; Sama Bitarafan

Volume 16, Issue 3 , July 2017, , Pages 125-129

  Background: To date, magnesium sulphate (MgSO4) is the treatment of choice for prevention of seizure in eclampsia and preeclampsia. However, there are some limitations in the administration of MgSO4 due to its tocolytic effects. The aim of this study was to compare the anticonvulsant and tocolytic effects ...  Read More